Syndax Pharmaceuticals Inc (SNDX)
Net Change in Cash
$205.58M
Quarterly · Period ending: · USD
SNDX Net Change in Cash
Latest reported$205.58Mperiod ending
Latest reported$205.58Mperiod ending
SNDX Quarterly Net Change in Cash ($108.00 → $205.58M)
Quarterly net change in cash
High-resolution chart · PNG
SNDX net change in cash history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Change in Cash (USD) |
|---|---|
| 205,584,000 | |
| -4,037,000 | |
| 18,007,000 | |
| 8,172,000 | |
| -45,357,000 | |
| -90,000 | |
| 21,064,000 | |
| 27,623,000 | |
| -9,219,000 | |
| -180,779,000 | |
| 200,844,000 | |
| -2,725,000 | |
| 39,860,000 | |
| -16,839,000 | |
| 2,979,000 | |
| -48,862,000 | |
| -68,534,000 | |
| -33,192,000 | |
| 150,532,000 | |
| 3,392,000 | |
| 3,655,000 | |
| -50,857,000 | |
| 58,887,000 | |
| 2,745,000 | |
| 8,982,000 | |
| 20,020,000 | |
| -6,073,000 | |
| 3,915,000 | |
| -31,450,000 | |
| 24,347,000 | |
| 7,064,000 | |
| -5,499,000 | |
| 4,224,000 | |
| -7,193,000 | |
| 14,436,000 | |
| -2,256,000 | |
| 632,000 | |
| -1,488,000 | |
| 11,091,000 | |
| -1,688,000 | |
| -8,746,000 | |
| 8,000 | |
| -31,035,000 | |
| 47,465,000 | |
| -2,533,000 | |
| -727,000 | |
| -1,580,000 | |
| 6,909,000 | |
| -2,160,000 | |
| -3,264,000 | |
| 5,067,000 | |
| 4,340,000 | |
| 111,000 | |
| 49,000 | |
| 108 |